Alavert Allergy

Quick links to important sections

Alavert Allergy

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alavert Allergy

Property Description
Active Ingredient Loratadine
Form Orally Disintegrating Tablet (ODT)
Pharmacological Class Second-Generation Antihistamine
Origin Synthetic
Route of Administration Oral

What Type of Medicine is Alavert Allergy?

Alavert Allergy is an over-the-counter (OTC), single-ingredient product whose therapeutic effect is delivered by the active compound, Loratadine. This substance is a synthetic, long-acting agent classified as a second-generation H1-receptor antagonist. It belongs to the broader antihistamine pharmacological class, a grouping that is clinically recognized for managing the body's response to histamine.

The classification as a second-generation antihistamine is significant as it indicates a lower potential for the medication to cross the blood-brain barrier compared to older compounds. Loratadine is a peripherally selective H1-antagonist. This chemical modification is key to the drug’s design as a non-sedating option, distinguishing it from first-generation agents.

Loratadine: The Core Mechanism and Non-Drowsy Purpose

The general therapeutic purpose of Alavert Allergy is to function as an anti-allergic agent by interrupting the cascade of reactions triggered by allergens. The active ingredient, Loratadine, achieves this by acting as a selective peripheral H1-blocker. This mechanism prevents the inflammatory chemical histamine, released by the body, from binding to its target receptors in peripheral tissues. A typical neutral use scenario for this kind of agent is providing relief for adults and older children during periods of high pollen or other environmental allergen exposure.

Loratadine is used for the symptomatic treatment of allergic rhinitis. The medication is intended to relieve the discomfort associated with general allergic responses.

The Form: Alavert Allergy Orally Disintegrating Tablet (ODT)

Alavert Allergy is administered via the oral route in the unique form of an orally disintegrating tablet (ODT), or quick-dissolving tablet. This specialized oral dosage form is formulated to rapidly break down upon contact with saliva on the tongue without requiring water for ingestion. This convenience factor, which contrasts with the standard tablet presentation of other Loratadine products, is facilitated by the tablet's solid excipient matrix.

What side effects are possible with Alavert Allergy?

Possible Side Effects and Safety Information

The safety profile of loratadine, the active ingredient in Alavert Allergy, is based on classifications from official regulatory documents. Adverse reactions are grouped by the body system affected and by frequency of occurrence, as determined by clinical trials and post-marketing reports.


Frequency-Classified Adverse Reactions

Side effects documented as Common (occurring in 1 to 10 in every 100 patients) often include Nervous System Disorders such as headache and somnolence (drowsiness), as well as fatigue and dry mouth. In children aged 2 to 12 years, nervousness is also classified as a common reaction.

Adverse reactions documented as Very Rare (affecting less than 1 in every 10,000 patients) typically arise from post-marketing experience and include serious reactions such as anaphylaxis (a severe allergic reaction), angioedema, convulsion, and effects on the cardiovascular system such as tachycardia (rapid heartbeat). Abnormalities in hepatic function have also been very rarely documented.


Population-Specific Safety Notes

The official labeling includes specific considerations for certain patient groups. Caution is noted for individuals with severe hepatic impairment (severe liver problems) and renal impairment (kidney problems) due to the potential for reduced clearance of the drug, which may require dose adjustment. Older adults may also experience greater overall exposure to the drug.


Regulatory Constraints

Loratadine may suppress or reduce the results of allergy skin tests. Regulatory guidelines suggest discontinuing use of the medicine for a period (e.g., approximately 48 hours) prior to such testing to ensure accurate results.

Overdose and Emergency Response

Overdose and When to Seek Help

Documented Overdose Manifestations

Overdose of the active ingredient, Loratadine, is officially documented by several clinical manifestations. The most frequently observed signs include somnolence (drowsiness), tachycardia (rapid heartbeat), and headache. Other documented presentations may include dizziness and agitation. In cases of severe exposure, there is a risk of increased anticholinergic symptoms and convulsions. For pediatric populations, the official labeling notes an increased potential for severe toxicity, including central nervous system (CNS) stimulation and seizures.


Required Emergency Action

If an overdose is suspected, official government guidance mandates that the patient seek immediate medical attention. It is required to contact a Poison Control Center right away or call emergency services. Urgent medical help is necessary for any suspected overdose, particularly if severe symptoms such as collapse, breathing trouble, or an inability to be awakened are observed.


Clinical Management and Constraints

Treatment for Loratadine overdose is officially described as symptomatic and supportive, as no specific antidote is known. Procedures to remove the unabsorbed drug, such as administering activated charcoal as a slurry with water or performing gastric lavage, may be considered under medical supervision. The active ingredient is confirmed to be not effectively removed by haemodialysis. Close observation and continued medical monitoring are required following emergency intervention.

Therapeutic Uses of Alavert Allergy

Quick Facts: Uses and Benefits

  • Relief Domain: Symptoms associated with upper respiratory allergies (hay fever).
  • Main Benefits: May help alleviate sneezing, runny nose, and itching.
  • Targeted Symptoms: Itchy, watery eyes; itching of the nose or throat.

Alavert Allergy (loratadine) is indicated for the temporary management of symptoms resulting from hay fever or other upper respiratory allergies. The established therapeutic benefit is the potential to relieve common allergy complaints.

Its use may support the reduction of sneezing and a runny nose. Additionally, it is used to address the uncomfortable sensation of itching, specifically in the nose, throat, and eyes. This medication may also help with watery eyes associated with allergic reactions. It is a non-drowsy formulation when taken according to directions.

Regulatory References

  1. NIH MedlinePlus guidance on Loratadine

Eligibility and Restrictions for Use

The eligibility for using Alavert Allergy (loratadine 10 mg orally disintegrating tablet) is strictly defined by official regulatory documentation, covering specific age groups, underlying health conditions, and absolute contraindications.

Populations Excluded from Use

Use is contraindicated for individuals with a known hypersensitivity or allergic reaction to loratadine or any other ingredient in the product. The orally disintegrating tablet (ODT) formulation contains phenylalanine (aspartame) and must not be used by patients with Phenylketonuria (PKU).

Age and Conditional Eligibility

The product is formally established as safe and effective for adults and children 6 years of age and over. Use in children under 6 years of age is not recommended for self-medication, as safety and efficacy are not established, and requires consultation with a doctor.

Special Populations Requiring Caution

Individuals with liver or kidney disease must ask a doctor before use, as regulatory guidelines suggest a dose adjustment may be necessary due to the drug's altered clearance in these populations. If pregnant or breast-feeding, a health professional must be consulted, as use is generally not recommended due to potential excretion into breast milk or insufficient established safety data.

What should I know about interactions with other medicines?

Alavert Allergy, which contains the active ingredient loratadine, is generally known for having fewer significant drug interactions compared to older-generation antihistamines. However, interactions can still occur and may alter how the medicine works or increase the risk of side effects. It is important to inform a healthcare provider or pharmacist about all prescription and over-the-counter drugs, vitamins, and herbal supplements currently being taken.

Medications that may increase Alavert Allergy levels

Certain medicines can interfere with the liver enzymes responsible for breaking down loratadine. This can lead to increased concentrations of loratadine in the blood, potentially elevating the risk of adverse effects. Examples of such medications include:

  • Antifungal medicines: Ketoconazole, Itraconazole
  • Antibiotics: Erythromycin, Clarithromycin
  • Heart rhythm medicine: Amiodarone
  • Indigestion/Ulcer medicine: Cimetidine

Products that may worsen side effects

Although loratadine is classified as non-drowsy, combining it with other substances that cause central nervous system depression can increase the likelihood of side effects such as drowsiness or dizziness. This includes:

  • Alcohol
  • Other antihistamines (e.g., diphenhydramine)
  • Sedatives or tranquilizers

There are no known significant interactions between Alavert Allergy (loratadine) and common painkillers like ibuprofen or acetaminophen. Always follow the advice of a healthcare professional regarding drug combinations.

Mechanism of Action

Histamine H1 Receptor Blockade

Alavert Allergy’s active ingredient, loratadine, acts as a competitive inverse agonist/antagonist at the Peripheral Histamine H1 receptors. This molecular interaction stabilizes the receptor’s inactive conformation, preventing the binding of histamine and thereby interrupting the signal transduction cascade initiated by histamine binding.


Targeted Modulation of Peripheral Systems

Loratadine is chemically characterized by its poor penetration of the Blood-Brain Barrier (BBB). This mechanism allows the drug to effectively modulate histamine signaling in peripheral systems—specifically receptors on vascular endothelium, smooth muscle, and sensory nerves—while resulting in minimal interaction with Central Nervous System H1 receptors.


Physiological Impact on Vascular and Sensory Pathways

By interrupting the histamine cascade, the drug counteracts histamine's effect on vascular permeability and interferes with histamine-mediated sensory nerve stimulation. This physiological modulation impacts the pathways that lead to localized increases in tissue fluid accumulation and afferent nerve activation in the periphery.

Dosage and Administration Information

Dosing and Administration for Alavert Allergy

Alavert Allergy (loratadine 10 mg orally disintegrating tablet) is intended for oral use. Adherence to the specified dose and administration technique is recommended as outlined in the product information.

Age Group Standard Dose Maximum Frequency Administration Notes
Adults and Children 6 years and over 1 tablet (10 mg) Once Daily (Not more than 1 tablet in 24 hours) Place 1 tablet on tongue; tablet disintegrates with or without water.
Children under 6 years of age Ask a doctor Consult a physician A doctor must be consulted before use.
Consumers with liver or kidney disease Ask a doctor Consult a physician A doctor should determine if a different dose is required.

Procedural Steps

  1. The tablet must be used immediately after opening the individual blister unit.
  2. Place the single tablet directly on the tongue.
  3. Allow the tablet to dissolve completely on the tongue. This step can be performed with or without water.

Special Handling

This product contains phenylalanine (e.g., 8.4 mg per tablet) and must be handled according to specific safety information for phenylketonurics.

Recent Clinical Evidence

Alavert Allergy: Recent Clinical Evidence

Alavert Allergy’s therapeutic component, Loratadine, has been the subject of extensive research used for evaluation. This research primarily relies on highly structured study designs, such as randomized controlled trials (RCTs) and comprehensive systematic reviews.


Evidence for Use in Allergic Rhinitis (Hay Fever)

The foundation for understanding how Loratadine was studied for allergic rhinitis comes from numerous RCTs. Research primarily examined outcomes related to physical discomfort using Total Symptom Scores (TSS). Specific measures included sneezing, runny nose, nasal itching, and ocular symptoms. The findings describe patterns observed in studies conducted on adults and adolescents, and systematic reviews contribute to the existing body of evidence.


Evidence for Use in Chronic Hives (Urticaria)

Research also explored the role of Loratadine in conditions characterized by fluctuating manifestations, such as Chronic Idiopathic Urticaria (CIU), or persistent hives. Studies examined patient-reported outcomes describing perceived discomfort, primarily tracking measures of pruritus (itching) and the size and number of wheals (hives). The evidence base consists primarily of RCTs evaluated in adult and adolescent populations.


Evidence in Different Age Groups and Long-Term Research

The research examined symptoms in varying age groups, including adults, adolescents, and children aged 6 and older. Data for groups such as children under the age of six remain limited for this context, and results apply only to the populations studied. Furthermore, the evidence base primarily consists of data collected over defined time intervals that are generally short- to intermediate-term. Long-term effects regarding the durability of response or maintenance of effect are not fully established.


What Research Gaps and Uncertainties Exist

The evidence highlights where research is still ongoing. A key limitation is the inconsistency in findings regarding relief for nasal congestion. Additionally, comparative evidence is lacking for certain head-to-head performance comparisons among all similar second-generation agents. The limited follow-up durations mean long-term effects on factors like quality of life are not fully characterized. Research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References Loratadine 10 MG (OTC) Drug Label - Uses and Dosing for Allergic Rhinitis and Urticaria

Frequently Asked Questions (FAQ)

Common questions about Alavert Allergy (FAQ)


Q: Is Alavert Allergy the same as Claritin?

A: Alavert Allergy and Claritin are both brand names for products that contain the same active ingredient, which is loratadine. The official information describes loratadine as the therapeutic component used to provide relief from allergy symptoms.


Q: How quickly does Alavert Allergy start to work?

A: Studies and official information indicate that the antihistaminic effect of a single dose is usually apparent within 1 to 4 hours after administration. This onset time reflects the rate at which the active ingredient is absorbed and begins to act on the body's histamine receptors.


Q: Is Alavert Allergy considered a non-drowsy allergy medicine?

A: The active ingredient is a long-acting antihistamine that is associated with a lower incidence of sedation compared to older antihistamines. This action is consistent with a lower risk of central nervous system effects, such as drowsiness. Despite this classification, regulatory documents still list drowsiness (somnolence) as a commonly reported side effect.


Q: Are there any food or drinks to avoid while taking Alavert Allergy?

A: The official product information notes that the medication can be taken with or without water. While food does not prevent the medication from working, it may increase the extent of the active ingredient's absorption and can slightly delay the time it takes for the concentration to peak in the body.


Q: Is Alavert Allergy safe for older adults to use?

A: Regulatory dosing recommendations do not inherently differ for older adults. However, caution is advised for any individuals who have underlying liver or kidney disease, which may affect clearance. In such cases, a dose adjustment may be necessary, and consulting a health professional is generally noted in official information.


Q: What types of allergy symptoms is Alavert Allergy approved to treat?

A: The product is approved for the symptomatic treatment of conditions such as seasonal allergic rhinitis, commonly known as hay fever. This includes relieving symptoms such as sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat.


Q: Are there specific warnings about driving or operating machinery while using this medicine?

A: Official labeling contains a clear warning to not take more than directed. This precaution is in place because taking more than the recommended amount may cause drowsiness, which could impair the ability to drive or operate machinery safely.


Q: Can taking Alavert Allergy cause dry mouth or dry eyes?

A: Dry mouth is listed in regulatory documents as a commonly reported adverse event associated with the active ingredient. Dry eyes are not listed among the common adverse events in regulatory documents.


Q: Can taking too much Alavert Allergy cause serious side effects?

A: Taking more than the directed dose may cause drowsiness. In cases of overdose, official information indicates a risk of significant toxicity, which includes effects such as mydriasis (dilated pupils), urinary retention, and agitation.


Q: Does Alavert Allergy contain pseudoephedrine or any decongestants?

A: The single-ingredient product, Alavert Allergy, contains only the active antihistamine ingredient, loratadine. It does not contain pseudoephedrine or any other decongestant components.


Q: Is it true that Alavert Allergy only treats symptoms and doesn't cure allergies?

A: The product is indicated for the symptomatic treatment of allergic conditions. This means the medication works to relieve the uncomfortable effects of an allergic reaction rather than addressing the underlying cause of the allergy itself.


Q: What evidence supports the use of Alavert Allergy for perennial (year-round) allergies?

A: The active ingredient is approved for seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives). The active ingredient is generally indicated for allergic rhinitis, and some monographs mention its use across a range of allergic conditions beyond just seasonal hay fever.


Q: How is the active ingredient in Alavert Allergy eliminated from the body?

A: The active ingredient is extensively metabolized (broken down) primarily in the liver. Official data indicates that approximately 80% of the dose is then excreted from the body in roughly equal amounts via the urine and feces as inactive metabolites.


Q: Does the time of day matter when taking Alavert Allergy?

A: The recommended dosing is once daily, meaning it should be taken once every 24 hours. The official product information does not specify a required time of day (morning or night), allowing flexibility in administration.


Q: What is the intended duration of relief from a single dose of Alavert Allergy?

A: The antihistaminic effect from a single dose is described in official sources as persisting for greater than 24 hours. This duration is consistent with the product’s once-daily dosing instruction.


Q: Is Alavert Allergy safe for women who are pregnant or breastfeeding?

A: Official labeling states that individuals who are pregnant or breastfeeding should ask a health professional before using this medication.


Q: What is the relationship between loratadine and desloratadine?

A: Loratadine, the active ingredient, is converted by the body into its major active substance, descarboethoxyloratadine, also known as desloratadine. This conversion process is known as metabolism.


Q: Can people with glaucoma safely use Alavert Allergy?

A: The active ingredient is a second-generation antihistamine which is associated with minimal anticholinergic effects, unlike older antihistamines. For individuals with pre-existing conditions like glaucoma, official guidance suggests consulting a health professional before use.


Q: What is the primary purpose of the 'inactive' ingredients listed on the label?

A: Inactive ingredients are defined as components of the product that do not contribute to the medication's therapeutic effects. Their purpose is generally structural, such as providing flavor or color, or aiding in the tablet's dissolution and final form.


Q: How does the active component of Alavert Allergy get into the bloodstream?

A: The active ingredient is rapidly absorbed from the gastrointestinal tract following oral administration. Once absorbed, it is distributed to the target tissues where it begins acting on histamine receptors.


Q: Is it required to take Alavert Allergy with food?

A: The medication is absorbed following oral administration with or without water. While taking it with food is not a requirement, it is noted that food increases the total amount of the active ingredient absorbed.


Q: Does Alavert Allergy help with indoor allergens like dust and pet dander?

A: The medication is indicated for the symptomatic treatment of allergic rhinitis. This indication applies to symptoms caused by a variety of known triggers, including both indoor and outdoor allergens.

How should Alavert Allergy be stored and disposed of?

Alavert Allergy (loratadine orally disintegrating tablets) must be stored and handled according to the official specifications provided in its regulatory labeling.

Storage Category Requirement Stability Rule
Temperature Store at 20-25 C (68-77 F) Protect from freezing and excessive heat.
Environment Keep in a dry place, protected from moisture and direct light. Use the tablet immediately after opening the individual blister.
Packaging Do not use if the individual blister unit is open or torn. Keep the medication in its container, tightly closed.

For child safety, the product is required to be kept out of reach of children. The labeling does not provide product-specific instructions for the disposal of unused or expired medicine. Disposal should follow general federal and local guidelines for safe medicine discarding, such as using drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Alavert Allergy found in:

A-Z Index: